Search research articles
Contact Us
Filters
Showing results (131-140 of 189) with videos related to
Page
of 19
Sort By:
Southern African Journal of HIV Medicine
|
March 24, 2018
Guideline on the management of occupational and non-occupational exposure to the human immunodeficiency virus and recommendations for post-exposure prophylaxis: 2015 Update
Michelle Moorhouse, Linda G Bekker, Vivian Black, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
December 2, 2025
The QuinteT Recruitment Intervention and its Role in Oncology Randomised Controlled Trials
L Wallis, J Wade, N Farrar, et al.
AIDS Research and Therapy
|
October 19, 2010
A comparative analysis of HIV drug resistance interpretation based on short reverse transcriptase sequences versus full sequences
Kim Steegen, Michelle Bronze, Elke Van Craenenbroeck, et al.
Plos One
|
April 13, 2012
HIV-1 phenotypic reverse transcriptase inhibitor drug resistance test interpretation is not dependent on the subtype of the virus backbone
Michelle Bronze, Kim Steegen, Carole L Wallis, et al.
Carcinogenesis
|
April 28, 2000
Dietary choline restriction causes complex I dysfunction and increased H(2)O(2) generation in liver mitochondria
K Hensley, Y Kotake, H Sang, et al.
Antimicrobial Agents and Chemotherapy
|
November 30, 2016
Frequent Cross-Resistance to Dapivirine in HIV-1 Subtype C-Infected Individuals after First-Line Antiretroviral Therapy Failure in South Africa
Kerri J Penrose, Carole L Wallis, Chanson J Brumme, et al.
Antiviral Chemistry & Chemotherapy
|
March 24, 2018
Frequent cross-resistance to rilpivirine among subtype C HIV-1 from first-line antiretroviral therapy failures in South Africa
Kerri J Penrose, Chanson J Brumme, Maritsa Scoulos-Hanson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 24, 2012
Frequent emergence of N348I in HIV-1 subtype C reverse transcriptase with failure of initial therapy reduces susceptibility to reverse-transcriptase inhibitors
Jessica H Brehm, Dianna L Koontz, Carole L Wallis, et al.
Journal of Clinical Microbiology
|
April 19, 2013
Development and evaluation of an affordable real-time qualitative assay for determining HIV-1 virological failure in plasma and dried blood spots
Susan C Aitken, Aletta Kliphuis, Michelle Bronze, et al.
Southern African Journal of HIV Medicine
|
December 23, 2020
Southern African guidelines on the safe, easy and effective use of pre-exposure prophylaxis: 2020
Linda-Gail Bekker, Benjamin Brown, Dvora Joseph-Davey, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 189) with videos related to
Sort By:
Page
of 19
Southern African Journal of HIV Medicine
|
March 24, 2018
Guideline on the management of occupational and non-occupational exposure to the human immunodeficiency virus and recommendations for post-exposure prophylaxis: 2015 Update
Michelle Moorhouse, Linda G Bekker, Vivian Black, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
December 2, 2025
The QuinteT Recruitment Intervention and its Role in Oncology Randomised Controlled Trials
L Wallis, J Wade, N Farrar, et al.
AIDS Research and Therapy
|
October 19, 2010
A comparative analysis of HIV drug resistance interpretation based on short reverse transcriptase sequences versus full sequences
Kim Steegen, Michelle Bronze, Elke Van Craenenbroeck, et al.
Plos One
|
April 13, 2012
HIV-1 phenotypic reverse transcriptase inhibitor drug resistance test interpretation is not dependent on the subtype of the virus backbone
Michelle Bronze, Kim Steegen, Carole L Wallis, et al.
Carcinogenesis
|
April 28, 2000
Dietary choline restriction causes complex I dysfunction and increased H(2)O(2) generation in liver mitochondria
K Hensley, Y Kotake, H Sang, et al.
Antimicrobial Agents and Chemotherapy
|
November 30, 2016
Frequent Cross-Resistance to Dapivirine in HIV-1 Subtype C-Infected Individuals after First-Line Antiretroviral Therapy Failure in South Africa
Kerri J Penrose, Carole L Wallis, Chanson J Brumme, et al.
Antiviral Chemistry & Chemotherapy
|
March 24, 2018
Frequent cross-resistance to rilpivirine among subtype C HIV-1 from first-line antiretroviral therapy failures in South Africa
Kerri J Penrose, Chanson J Brumme, Maritsa Scoulos-Hanson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 24, 2012
Frequent emergence of N348I in HIV-1 subtype C reverse transcriptase with failure of initial therapy reduces susceptibility to reverse-transcriptase inhibitors
Jessica H Brehm, Dianna L Koontz, Carole L Wallis, et al.
Journal of Clinical Microbiology
|
April 19, 2013
Development and evaluation of an affordable real-time qualitative assay for determining HIV-1 virological failure in plasma and dried blood spots
Susan C Aitken, Aletta Kliphuis, Michelle Bronze, et al.
Southern African Journal of HIV Medicine
|
December 23, 2020
Southern African guidelines on the safe, easy and effective use of pre-exposure prophylaxis: 2020
Linda-Gail Bekker, Benjamin Brown, Dvora Joseph-Davey, et al.
Page
of 19